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Introduction: Owing to increasing numbers of
decompressive craniectomies in patients with
malignant middle cerebral artery infarction,
cranioplastic surgery becomes more relevant. However,
the current literature mainly consists of retrospective
single-centre (evidence class III) studies. This leads to
a wide variability of technical approaches and clinical
outcomes. To improve our knowledge about the key
elements of cranioplasty, which may help optimising
clinical treatment and long-term outcome, a
prospective multicentre registry across Germany,
Austria and Switzerland will be established.
Methods: All patients undergoing cranioplastic surgery
in participating centres will be invited to join the registry.
Technical methods, materials, medical history, adverse
events and clinical outcome measures, including
modified Rankin scale and EQ-5D, will be assessed at
several time points. Patients will be accessible to
inclusion either at initial decompressive surgery or when
cranioplasty is planned. Scheduled monitoring will be
carried out at time of inclusion and subsequently at time
of discharge, if any readmission is necessary, and at
follow-up presentation. Cosmetic results and patient
satisfaction will also be assessed. Collected data will be
managed and statistically analysed by an independent
biometric institute. The primary endpoint will be
mortality, need for operative revision and neurological
status at 3 months following cranioplasty.
Ethics and dissemination: Ethics approval was
obtained at all participating centres. The registry will
provide reliable prospective evidence on surgical
techniques, used materials, adverse events and
functional outcome, to optimise patient treatment. We
expect this study to give new insights in the treatment of
skull defects and to provide a basis for future evidence-
based therapy regarding cranioplastic surgery.
Trial registration number: This trial is indexed in the
German Clinical Trials Register (DRKS-ID:
DRKS00007931). The Universal Trial Number (UTN)
is U1111-1168-7425.
INTRODUCTION
Several prospective clinical trials have demon-
strated that early decompressive craniectomy
(DC) increases survival in patients with space-
occupying middle cerebral artery (MCA)
infarction by reducing intracranial pressure.
Subsequently, numbers of DCs are continu-
ously rising.1–5 Large cerebral infarctions
cause space-occupying brain oedema, which is
considered the main reason for a mortality
rate of up to 80%.6–8 Despite best conservative
treatment, outcome was generally poor before
establishing DC as an early treatment option.6
Recently, analyses of prospective randomised
clinical trials including the DECIMAL
(Decompressive Craniectomy In
Malignant MCA Infarction), HAMLET
(Hemicraniectomy After Middle cerebral
artery infarction with Life-threatening Edema
Trial), DESTINY I and DESTINY II
(Decompressive Surgery for the Treatment of
malignant Infarction of the middle cerebral
Strengths and limitations of this study
▪ The German Cranial Reconstruction Registry
(GCRR) is a prospectively conducted, multicen-
tre, international, open registry study in which
patients will be observed long term.
▪ Owing to the prospective international nature
(Germany, Austria, Switzerland), a very wide
range of cranioplastic treatment options will be
detected. Similar publications and studies are
only monocentric.
▪ The registry includes patients with decompres-
sive craniectomies in a wide range of acute
diseases (eg, traumatic brain injuries, space-
occupying cerebral infarction, subarachnoid and
intracerebral haemorrhage, etc) as well as
destructive or osteolytic bone tumours.
▪ A limitation of the study is that the GCRR is not
a randomised study, but only a pure observa-
tional study. Specific treatment strategies will not
be compared against each other.
▪ One of the strengths as well as simultaneous
limitation of this study is the planned long obser-
vation period of up to 10 years. There is the pos-
sibility of a high number of participants lost to
follow-up.
Giese H, et al. BMJ Open 2015;5:e009273. doi:10.1136/bmjopen-2015-009273 1
Open Access Protocol
group.bmj.com on September 12, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
artery) trials, and a prospective pooled data analysis of the
ﬁrst three trials mentioned above, proved the beneﬁt for
patients with malignant MCA infarction.2–4 9–11 The prob-
ability of survival for patients aged 60 years and younger
increases up to 80% following DC (vs 28% without DC)
and the probability of survival with a modiﬁed Rankin
scale (mRS) of ≤3 doubles.2 Based on these beneﬁcial
experiences, DC procedures have also been proposed as a
therapeutic option in refractory intracranial hypertension
or malignant brain oedema due to traumatic brain injury
(TBI), acute subdural haematoma, subarachnoidal haem-
orrhage or encephalitis.12–17
Each successful DC requires a secondary operative pro-
cedure: cranioplasty (CP). Besides reﬁtting the integrity of
the skull, protecting the brain and restoring the cosmetic
aspect, CPs have gained a major focus in the rehabilitation
process. CPs may also improve the neurological condition
of patients with a so-called ‘sinking skin ﬂap syndrome’,
and associated deteriorations, dramatically.18
Furthermore, CP may play an important role in recon-
struction procedures following excision of primary osseous
tumours, meningiomas inﬁltrating the bone and simple
removal of bone ﬂaps following postoperative infection.
Both DC and CP are performed with increasing fre-
quency, while published series reveal a 20–50% complica-
tion rate. Complications following DC after malignant
infarction include haematomas, meningitis, seizures and
wound infections.19 Major complications of DC after
severe TBI are herniation of the brain tissue through
defects (34%), subdural effusions (54%) and hydroceph-
alus (14%).20 One-third of all patients undergoing CP
suffer from complications,21–23 of which wound infections
and wound healing disorders, in up to 25% of patients,
are of major importance, as is aseptic bone necrosis, in up
to 18%.21 24 Although some predictors, such as multiple
fractures within the bone ﬂap, wound infection after CP
and insecure ﬁxation of the bone, may increase bone
resorption rates, the impact of other factors, such as bone
ﬂap preservation or timing of CP, is unknown.21 25 In the
absence of prospective clinical studies, and based on
numerous retrospective monocentre studies alone, one
cannot reach consensus regarding timing of CPs, materials
and perioperative management.21 23 26–29
The aims of this international prospective multicentre
register are to (1) identify surgical and medical factors
with a strong inﬂuence on patient’s outcome and func-
tional status, and (2) establish an evidence-based thera-
peutic approach optimising timing and the procedures
themselves, thus minimising perioperative and post-
operative complication rates and improving clinical
outcome in this group of patients.
METHODS
Study design
The German Cranial Reconstruction Registry (GCRR) is
a prospectively conducted, multicentre, open registry, in
which patients will be observed long term. The study is a
procedure-speciﬁc registry, initiated by a consortium of
individual members of the Section for Neurotrauma and
Intensive Care in Neurosurgery of the Deutsche
Gesellschaft für Neurochirurgie (DGNC). A total of 10
German neurosurgical departments have constituted a
Steering Committee, which will be responsible for the
scientiﬁc goals of the registry and guarantee the inde-
pendence of the data analysis performed by a biometric
institute. In 2014, organisation and goals of the registry
as well as the implementation of the GCRR were deter-
mined. Neurosurgical units in Germany, Austria and
Switzerland conducting DC and CPs are invited to join
the registry and to recruit patients.
Study setting and type of participants
All patients undergoing CP are included in the study.
Inclusion criteria are all clinical conditions that require a
temporary removal of the skull, for example: TBIs, space-
occupying cerebral infarction and subarachnoid haemor-
rhage as well as destructive or osteolytic bone tumours.
Patients undergoing craniectomy without CP (eg, subocci-
pital), craniosynostosis repair or skull base approaches with
complex reconstruction, will not be included (table 1).
Patients can be included at two time points: either at the
initial event of DC or at readmission for CP.
Informed consent
Written informed consent for this study will be obtained
from the patient or the patient’s authorised representa-
tive prior to study inclusion. The study will be conducted
in accordance with the provisions of the Declaration of
Helsinki.
Data collection
According to a standardised questionnaire for DC and
CP, patient-speciﬁc data, risk factors, surgical details,
materials for CP, and intraoperative and postoperative
complications, will be recorded. Data acquisition will be
paper-based (case report form, CRF), and patient-
speciﬁc data will be anonymised by the study centre.
The data will then be transferred to the Department of
Medical Biometry Heidelberg (Institute of Medical
Biometry and Informatics, IMBI) and transmitted into
an electronic database. Despite anonymous data acquisi-
tion, patient tracking remains possible for analysing
speciﬁc events such as clusters of complications or unex-
pected severe events.
Case report form
The specially designed and developed questionnaire
(CRF) consists of four different parts (ﬁgure 1).
Craniectomy: The ﬁrst part of the CRF covers the initial
surgery, craniectomy. In addition to patient data (sex,
age) and diagnosis, the initial neurological status
(Glasgow Coma Scale (GCS), National Institute of Health
Stroke Scale (NIHSS), World Federation of
Neurosurgical Societies Scale (WFNS), Hunt and Hess),
medical history (American Society of Anesthesiologists
(ASA) Physical Status Classiﬁcation), comorbidities (eg,
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diabetes, arterial hypertension, coagulopathy) and risk
factors (eg, smoking status, drugs), is recorded. In add-
ition, surgical data such as localisation of skin incision,
trephination size and localisation, dura opening and
closure technique (duraplasty) as well as materials used
(eg, suture material and technique, drainage), are regis-
tered. Moreover, the experience of the surgeon, duration
of operation, amount of blood loss and any perioperative
antibiotic therapy given, will be documented. Finally, the
storage of the bone and perioperative complications are
listed. The initial observation period following DC (part
1) will end with discharge of the patient, where neuro-
logical status is recorded (Glasgow Outcome Scale
(GOS), modiﬁed Ranking Scale (mRS), NIHSS).
Cranioplasty: The second part of the CRF covers all par-
ticular details of CP. Here, new patients can be included
independently of the prior procedure, for example,
when operated earlier at another institution. Again, pre-
operative data and the current neurological status are
recorded. Particular attention is paid to the size of crani-
otomy and the type of CP (autologous vs alloplastic). All
types of materials are included (eg, plastic, ceramic,
titanium alloy, etc) and will be distinguished between
patient-speciﬁc and hand-made CP. Details for ﬁtting
and ﬁxating the material, simultaneous implantation of
a CSF-shunt as well as standard parameters (suture
material, size and number of drainage apparatus, peri-
operative antibiotics) will be covered. Similar to during
Figure 1 Study protocol of the
German Cranial Reconstruction
Registry (GCRR): using a
structured questionnaire (for
physicians and patients), patients’
clinical pathways will be
monitored in four steps, from the
craniectomy, over the cranioplasty
and up to the long-term follow-up.
Table 1 Inclusion and exclusion criteria for patients to participate or not in the GCRR
Inclusion criteria Exclusion criteria
1. Patients with a clinical condition that requires temporary
removal of the cranial bone (DC)
▸ Space-occupying cerebral infarction
▸ Traumatic brain injury
▸ Subarachnoid haemorrhage
▸ Intracranial haemorrhage
▸ Sinus venous thrombosis
▸ Space-occupying cerebral infections
2. Patients after DC who now require surgical CP
3. Patients with osteolytic or bone-destructing tumours of the
skull
4. Legal age (≥18 years)
1. Patients with a clinical condition that requires
permanent removal of the cranial bone
2. Patients in palliative care
3. Patients with craniofacial malformations (eg,
craniosynostosis)
4. Patients who require skull base reconstruction
5. Patients after suboccipital DC
CP, cranioplasty; DC, decompressive craniectomy; GCRR, German Cranial Reconstruction Registry.
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the DC procedure, operating duration and amount of
blood loss will be captured.
Postoperative monitoring: The third part addresses all
questions of the clinical follow-up at time of discharge.
Acute complications such as bleeding events, seizures,
wound healing disorders, infections and CSF ﬁstulas,
will be recorded. Removal of drains and control
images are documented as well if surgical revisions or
intensive care surveillance and/or treatment have
been required in case of any complications. On dis-
charge, neurological status will be recorded (GOS,
mRs) again. This CRF can be used for any readmission
due to complications or further surgical treatment as
well.
Follow-up: Long-term clinical outcome after 12 months
will be recorded; this will be continued annually, and is
covered by a fourth part. Here, long-term complications
such as aseptic bone necrosis, loosening or displace-
ment of CP, wound healing disorders and revision pro-
cedures, if required, are recorded. Similar to in the
earlier step, neurological status (GOS, mRs), patient sat-
isfaction (SF12, EQ-5D) and cosmetic result will be
assessed.
Data management
Data collection will be performed locally and anonymised
for name and date of birth in an independent database,
then submitted to the Department of Medical Biometry
Heidelberg (IMBI). An interim analysis is planned after 2,
5 and 10 years, and it is estimated to include at least 80
patients per year. All results of the GCRR, including epi-
demiological data, surgical techniques, material for CP,
complications, risk factors and long-term outcome, will be
published and/or reported at respective scientiﬁc meet-
ings. This study is indexed in the German Clinical Trials
Register (DRKS-ID: DRKS00007931). The Universal Trial
Number (UTN) is U1111–1168–7425.
Statistics
Endpoints will be evaluated using descriptive statistics,
and the key ﬁgures of the distributions will be presented
in tables. Univariate analyses will allow for a ﬁrst over-
view of potentially inﬂuential factors. Depending on the
composition of the data, χ2, Mann-Whitney U and
t tests, or Pearson or Spearman correlation coefﬁcients,
will be conducted. Relationships between multiple inde-
pendent variables on the dependent variable(s) will be
tested using multivariate regression analysis. Missing
values will be replaced and estimated using multiple
imputations. Furthermore, sensitivity analysis will be exe-
cuted using complete-case analysis.
Registry reports
Results of the GCRR will be published by the Steering
Committee and distributed to all participating centres
following careful analysis by the IMBI.
DISCUSSION
DC and CP are of increasing importance in neurosurgery.
While they both are standard neurosurgical interven-
tions, and are supposed to be ‘simple’ and ‘extracerebral’
surgical procedures, complication rates are surprisingly
high and there is deﬁnitely a lack of evidence.
The GCRR is designed as a multicentre prospective
data collection to uncover risk factors of both proce-
dures, thus minimising complication rates, especially
regarding periprocedural wound infections, CSF lea-
kages and reasons for surgical revisions, as well as
improving long-term clinical and cosmetic outcome
focusing on CP materials, reasons for revision surgeries
and rehabilitation processes. The amount of data and
variety of aspects covered by this registry will give new
insight in DC and CP, enhancing our knowledge regard-
ing these ‘easy’ operative procedures. Currently,
DESTINY-R is evaluating the short-term and long-term
risks and beneﬁts of DC in patients with MCA infarction
in a large population routinely treated in neurological
and neurosurgical units.30 The GCRR takes a step
forward since it is not limited to one disease entity, and
features a procedure and follow-up procedure in great
detail. The effectiveness of registries and long-term sur-
veillance of neurosurgical implants has been well
demonstrated with, for example, the UK shunt registry.31
By the acquisition of nearly 33 000 CSF shunt-related
procedures, for example, the beneﬁt of antibiotic-coated
catheters could be proven.32 Similarly, a registry for CP
surgeries called ‘UK Cranial Reconstruction Registry
(UKCRR)’ was founded for the UK.33 Both the GCRR
and UKCRR have had overlap in the planning phase
and contents of both registries were harmonised.
Inspired by these successful registry projects, now the
GCRR will be initiated for Germany, Austria and
Switzerland.
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